Benzinga's Top Downgrades

Analysts at Barclays downgraded Bristol-Myers Squibb Company

from “overweight” to “equal-weight.” The target price for Bristol-Myers Squibb has been lowered from $65 to $46. Bristol-Myers Squibb's shares closed at $48.12 yesterday. Analysts at Raymond James downgraded Harley-Davidson

from “strong buy” to “market perform” and removed the price target of $84. Harley-Davidson's shares closed at $70.33 yesterday. Baird downgraded U.S. Bancorp

from “outperform” to “neutral.” The price target for U.S. Bancorp is set to $44. U.S. Bancorp's shares closed at $43.34 yesterday. Credit Suisse downgraded Hormel Foods

from “outperform” to “neutral.” Hormel's shares closed at $49.19 yesterday.